Skip to content

Satellos Bioscience Inc.

MSLE

CIK 0001421642 · Pharmaceutical Preparations · Nasdaq

  • ICO THERAPEUTICS INC (until 2019-09-10)
← back to feed
Revenue (TTM)
—
FY Dec 2025
Net Income (TTM)
−24.87M
−20.5% YoY FY Dec 2025
EPS Diluted (TTM)
−1.70
+21.3% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
9.8M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
15.46M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings